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Abstract
Introduction: Ducts-dependent pulmonary circulation is spectrum of congenital heart diseases that need urgent intervention to augment pulmonary blood. Systemic to pulmonary shunt is the classical surgical management. Stenting of
ductus arteriosus emerged in the last 2 decades as an alternative plausible intervention.
Objectives: To evaluate and compare the short and midterm effects of PDA stenting in compared to surgically placed
shunt for augmentation of pulmonary blood ﬂow looking to pulmonary artery (PA) branches growth, oxygen saturation
and suitability for second stage repair.
Methods: We conducted this prospective study in Cardiac Surgical Intensive Care Unit . Cases were divided into “stent
group” and “surgical shunt” group. Results were compared between two groups regarding oxygen saturation, mechanical ventilation duration, intensive care stay, mortality and morbidity. Growth of PA branches was assessed during
follow up by echocardiograph. Nakata index score was calculated by angiogram before second stage surgery and was
compared between both groups.
Results: 43 patients were included. Forty-two cases were offered stent as initial management. 6/42 cases failed stenting
(14%) and 3/42 (7%) required late BT shunt after PDA stenting. 10/43 cases ended up receiving BT shunt and were
counted as “surgical shunt group”. Stent group (33 cases) needed less mechanical ventilation (2.08 ± 0.65 vs.7.8 ± 4 days
with p ¼ 0.014), and less ICU stay compared with surgical shunt group (6.2 ± 1.02 vs. 14 ± 4.5 days, P ¼ 0.009). Both
groups achieved similar growth of pulmonary artery branches (p ¼ 0.6 for Z score of left pulmonary artery and P ¼ 0.8
for Z score for right pulmonary artery). Although “stent group” reached second stage surgery with lower O2 saturation
67.6 ± 4.6 vs. 80 ± 4.2 in “surgical shunt” group with P value ¼ 0.0002). Majority of patients in both groups had some PA
distortion and needed surgical reconstruction in main pulmonary artery or in its main branches during second stage
repair. 3 cases (7.1%) died soon post stenting versus none in surgical shunt group ( p value ¼ 0.57).
Conclusions: In neonates with ductus-dependent pulmonary circulation PDA stenting can be introduced as safe ﬁrst
possible option to augment pulmonary blood ﬂow with good outcome and suitable preparation for second stage
palliation.
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1. Introduction

Abbreviations

A

PA
PDA
BT
LOS
ICU
LLI
LPA
RPA
MV
PA VSD
PA

ortopulmonary shunt is applied to a wide
range of congenital heart diseases, collectively termed “ductus-dependent pulmonary circulation,” that will manifest early in neonatal life
after closure of ductus arteriosus.
Thus, placing a shunt between both circulatory
vessels is a must for survival of this group of patients. Before 1992, all these patients needed to undergo surgical shunt to maintain the perfusion
through stenotic or completely atretic outﬂow. In
the past two decades, however, patent ductus arteriosus (PDA) stenting has become a reliable palliative procedure to establish a safe and quick source
of pulmonary blood ﬂow [1].
Numerous studies have reported on the safety
and advantages of PDA stenting [2,3]. Although
PDA stenting may have some complications, such as
migration of stent, partial PDA stent coverage,
inadequate or asymmetric growth of pulmonary
artery (PA) branches, when compared with those
resulting from surgical shunt, such as phrenic nerve
injury, vocal cord palsy, or chylothorax, the former
is a less invasive procedure, particularly in relation
to postoperative care [1].
However, limited knowledge exists about the
viability and durability of PDA stents to facilitate
adequate perfusion to pulmonary circulation and to
maintain adequate growth of pulmonary branches
in order to enable the patients to undergo next-stage
surgery with minimal distortion of PA branches.
From this perspective, ductal stenting is a practical,
effective, safe, and less invasive method compared
with BlalockeTaussig (BT) shunt; however, longterm stent restenosis might be a concern [4].
In this study, we aimed to assess our center’s
experience with PDA stenting as an alternative
choice to BT shunt to help infants overcome their
defect (duct-dependent pulmonary circulation), and
prepare them for next-stage surgery, and discuss
short- and long-term outcomes of the procedures, in
particular their impact on growth and size of

pulmonary artery
Patent Ductus Arteriosus
Shunt Blalock Taussig shunt
length of intensive care stay
Intensive Care Unite
Lower Lobe Index
Left Pulmonary Artery
Right Pulmonary Artery
Mechanical Ventilation
Pulmonary atresia, Ventricular septal defect
Pulmonary atresia

pulmonary branches and the need for surgical
reconstruction during second-stage surgery.

2. Materials and methods
This was a prospective study performed in the
Cardiac Surgical Intensive Care Unit at Prince Sultan Cardiac Center-Qassim, Qassim, Saudi Arabia
between November 2012 and January 2019. After
Institutional Research Board approval, we included
all patients who underwent procedures for
augmentation of pulmonary blood ﬂow. Our institutional strategy is to offer PDA stenting for all patients weighing more than 2 kg as ﬁrst choice.
Demographic data such as age, weight, and sex
were collected. Perioperative data collected
included initial cardiac diagnosis, whether single or
biventricular pathway, and initial measurement of
pulmonary branches with its appropriate Z scores
calculated based on the Pediatric Heart Network
Echo Z-score Project. Data on mechanical ventilation before and after the procedure, prostaglandin
E2 infusion, PDA stent or surgical shunt (size and
length of stent/shunt size, use of more than one
stent to cover the PDA, need for reintervention, or
failed stent implantation) and postprocedure data
[oxygen saturation, duration of mechanical ventilation, length of stay (LOS) in intensive care unit
(ICU)] were also collected.
Cases were followed in the pediatric cardiac clinic
at 3- and 6-month intervals. Position of the stent or
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shunt was conﬁrmed by echocardiography, and
measurement of left PA and right PA diameter and
Z score were recorded in addition to body weight
and oxygen saturation. Patients who survived to
undergo second-stage surgery had the following
data recorded: age, oxygen saturation, and need for
pulmonary reconstruction. Routine cardiac catheterization was performed for most cases before the
second-stage surgery and the Nakata index score
was calculated. We accepted patients for surgery if
the Z score of PA branches is more than e2 standard
deviations with Nakata score above 140.
Cases were divided into two groups: successful
PDA stent group, which included all patients who
received PDA stent, and the failed PDA stent group,
which included patients who received BT shunt
directly or due to failed attempt of PDA stenting or
needing late shunt because of inadequate initial
stenting that resulted in abnormally low saturation.
Data were compared between these two groups in
terms of age, weight, oxygen saturation, duration of
mechanical ventilation, and LOS in the ICU;
following discharge, we compared the progress of
growth of PA branches and the need of reconstruction. All data were analyzed and compared
between two groups using GraphPad Prism
(GraphPad Software, San Diego, CA, USA).
Continuous data were analyzed between groups
using unpaired Student t test. Data are presented as
mean ± standard error of mean and p < 0.05 is
considered statistically signiﬁcant.

3. Results
Forty-three cases of duct-dependent pulmonary
circulation were included with complete data. Cases
were assigned to receive surgery via either biventricular pathway (n ¼ 27) or single ventricle pathway
(n ¼ 16). Two of the patients with single ventricle
had dominant right single ventricle. Of the 43 cases,
42 were initially referred for PDA stenting; the
remaining case was directed to surgical shunt
because of low body weight (<2 kg). Nine cases
initially assigned to receive PDA stent later had to
be referred to surgical shunt. As such, we had
Group 1 that included 33 cases requiring PDA
stenting and Group 2 that included 10 cases
requiring surgical shunt (Fig. 1). Table 1 summarizes the demographic data and variables considered for both groups.
Four (9.5%) patients from the successful stent
group (Group 1) died post-PDA stenting; whereas
three of the four cases died early [within 4 days after
the procedure (7.1%)], one died 3 months after
discharge from the hospital. The three cases that
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had early mortality had single ventricle physiology,
with their death attributed to either pulmonary
circulation stealing (n ¼ 2) or retroperitoneal
bleeding (n ¼ 2). The fourth case had out-of-hospital
cardiac arrest with an undetermined cause of late
death.
Patients in the PDA stent Group 1 had less duration of mechanical ventilation (2.08 ± 0.65 days),
compared with those in Group 2 (7.8 ± 4 days,
p ¼ 0.014) as well as shorter LOS in ICU (6.23 ± 1.02
vs. 14.6 ± 4.5 days, respectively, p ¼ 0.009; Table 1).
One case (3%) from the successful stent group
needed reintervention during hospital stay in ICU
and a second stent was reimplanted to cover the
entire ductus, whereas no intervention was needed
for any of the cases in Group 2. One case from each
group showed signs of low cardiac output because
of the placement of the large shunt and needed
peritoneal dialysis during ICU admission.
In Group 2 (n ¼ 10), ﬁve patients had tortuse PDA
so stent can’t be inserted and shifted to operation
room for surgical shunt. One case had stent migration to the right PA and because of signiﬁcant desaturation, the patient was transferred from ICU to the
operation theater to undergo urgent surgical stent
retrieval and shunt placement. Three patients underwent surgical shunting before second-stage
palliative surgery due to marked desaturation at the
age of 2, 9, and 12 months, respectively. The decision
to place a surgical shunt rather than directly performing second-stage repair in these three cases was
made because of borderline size of PA branches and
to allow further growth of PA branches, with pulsating PA ﬂow achieved through the surgical shunt,
before undergoing next-stage surgery (Table 2).
Femoral access was used in all cases for PDA
stenting. Two cases suffered from femoral artery
spasm and absent foot pulses after stenting that
required prolongation of anticoagulation management until improvement in pulse and recovery of
foot perfusion were achieved. Heparin infusion
(21.5 ± 1.3 IU/kg/h) was initiated poststent procedure in all stented cases until oral feed was established and oral aspirin was substituted.
No differences in growth of PA branches were
noted between the groups. All cases achieved
acceptable growth of pulmonary branches with
appropriate Z score. Twenty of 43 cases underwent
second-stage surgery. The successful PDA stent
group had lower oxygen saturation level following
second surgery compared with Group 2 (67 ± 4.6%
vs. 80 ± 4.2%, p ¼ 0.0002). The Nakata score for the
successful PDA stent group was 162 ± 26, compared
with 194.75 ± 47 for the failed PDA stent group
( p ¼ 0.55). Twelve of 15 patients (80%) in the
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Fig. 1. Distribution of 43 cases who had successful PDA stent or failed stent. PA ¼ pulmonary atresia; PDA ¼ patent ductus arteriosus.

Table 1. Comparison between the failed and successful stent groups.
Variable

PDA stent (n ¼ 33)

BT shunt (n ¼ 10)

p

Weight (kg)
Age (d)
RPA size (mm)
Z score of RPA
LPA size (mm)
Z score of LPA
Stent length (mm)
Stent size
Saturation postprocedure
MV duration (d)
Heparin dose (IU/kg)
LOS (d)
RPA size 2 (mm)
LPA size 2 mo (mm)
RPA before second stage (mm)
Z score of RPA
LPA before second stage (mm)
Z score of LPA
Nakata index
Number of cases who underwent second-stage surgery
Age at second procedure (mo)
Weight at second procedure (kg)
Saturation at second procedure
Early 28-d mortality
Reconstruction

3.5 ± 0.15 (35)
30 ± 10 (35)
3.6 ± 0.26 (26)
1.6 ± 0.23 (29)
3.6 ± 0.22 (26)
1.5 ± 0.25 (29)
20 ± 1.34 (32)
4.06 ± 0.05 (35)
84.9 ± 1.7 (32)
2.08 ± 0.65 (34)
21.5 ± 1.3 (22)
6.23 ± 1.02 (31)
5.04 ± 0.45 (16)
4.8 ± 0.5 (16)
6.04 ± 0.75 (16)
0.85 ± 0.5 (16)
5.9 ± 0.59 (15)
0.65 ± 0.4 (15)
162 ± 26 (13)
51% (15)
9.8 ± 1.3 (17)
7.8 ± 0.5 (17)
67.6 ± 4.6 (10)
3
12/15

3.3 ± 0.15 (6)
42 ± 17 (6)
3.5 ± 0.5 (2)
1.8 ± 0.8 (2)
3.5 ± 0.5 (2)
2 ± 0.83 (2)

0.59
0.6
0.9
0.8
0.2
0.6

3.9 ± 0.08 (6)
83 ± 1.9 (6)
7.8 ± 4 (5)

0.2
0.6
0.014

14.6 ± 4.5 (5)
3.5 ± 0.5 (3)
3.4 ± 0.5 (3)
6.2 ± 0.8 (3)
0.6 ± 0.6 (3)
6.67 ± 1.8 (3)
0.15 ± 1.3 (3)
194.7 ± 48 (3)
50% (5)
12.5 ± 1.8 (4)
9.5 ± 1.3 (3)
80 ± 4.2 (3)
0
3/5

0.009
0.9
0.29
0.93
0.8
0.6
0.5
0.55
0.35
0.2
0.0002
0.57
>0.99

BT shunt ¼ BlalockeTaussig shunt; LOS ¼ length of stay; LPA ¼ left pulmonary artery; MV ¼ mechanical ventilation; PDA ¼ patent
ductus arteriosus; RPA ¼ right pulmonary artery.
33 in group one and 10 in group 2 while the parenthesis is presented the number of data collected and there are some patient entered the
two group.
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Table 2. Cases that required emergency surgical shunt poststent placement.
Case

Type of lesion

Age (mo)

O2 saturation (%)

Type of surgery

1
2
3

PA VSD
PA intact septum
PA VSD

15
3
14

65
55
65

BT shunt
BT shunt followed by central shunt
BT shunt followed by Rastelli

BT shunt ¼ BlalockeTaussig shunt; PA ¼ pulmonary atresia; VSD ¼ ventricular septal defect.

successful PDA stent group and three of ﬁve cases
(60%) in the failed PDA stent group needed reconstruction of PA branches during second-stage surgery ( p ¼ 0.78).

4. Discussion
Patients with duct-dependent pulmonary circulation physiology need prompt treatment in the ﬁrst
few days of life to ensure an adequate and stable
source of pulmonary blood ﬂow. Stenting of the
PDA has been proposed since the early 1990 s for
maintaining ductus patency as an alternative to
surgical shunt [1]. Initially published results were
encouraging with high success rate, achieving up to
93% in a single-center experience over 10 years [5].
By contrast, Alwi et al. [6] reported 91% success rate,
whereas we achieved an initial success rate of 85%
for stenting in our study, although the success rate
for PDA stent as the only management until the
second-stage surgery was almost 70%.
Difﬁculty to approach ductus arteriosus is usually
because of torturous nature and complex
morphology. The ductus arteriosus is markedly
varied with regard to its origin from the aorta, size
and shape, length, tortuosity, and its insertion into
the PA [7]. Thus, evaluation of the anatomy by
echocardiography and angiogram before attempting
stenting is mandatory to enable the experts to
decide on the best approach. Failure of stenting or
deciding not to stent is an option chosen in the
catheter laboratory. In our study, ductus could not
be approached in 11.5% of cases, while Alwi et al. [6]
reported unsuccessful stenting in 8.9% of cases.
The need for reintervention after PDA stent may
occur early during initial admission or late after
discharge from hospital. During immediate management, we had one case that had stent migration
and needed emergency stent retrieval with BT shunt
(3%). Schranz et al. [8] reported 3.7% stent migration
in their 10-year experience, whereas in the study by
Vida et al. [9], 13% of patients with PDA stent underwent emergency stent retrieval and surgical
shunting due to stent migration into the LPA. In this
study, three of 42 (9%) patients with PDA stenting
needed stent retrieval and surgical shunting during
follow-up due to signiﬁcant cyanosis. Glatz et al. [1]

reported surgical revision of PDA stent in 50% of
their patients with PDA.
Ideally, stent length should cover the entire ductus,
assuming 15e20% shortening will occur upon full
expansion [7]. Of the 33 stent cases (3%) in our study,
only one patient was required to go back to the
catheter laboratory to implant an additional stent.
In a hospital setting mortality related to surgical
procedures is not infrequent. Glatz et al. [1] reported
mortality rates of around 6.6% and 10.4% in patients
who received stent and BT shunt, whereas Santoro
et al. [5] reported in-hospital mortality rates of 17.6%
and 3.6% for patients in the stent and surgical shunt
groups, respectively. In our study, the mortality rate
in the stent group was 7.1%, but no deaths were
reported in patients who underwent BT shunting,
which comprised a small group, and thus difﬁcult to
be compared with. In general, despite wide clinical
experience, neonatal mortality after surgical systemic-to-pulmonary shunting remains between 5%
and 9% in the past two decades, based on data from
UK centers [10].
Petrucci et al. [11] analyzed data retrieved from
The Society of Thoracic Surgeons Congenital Heart
Surgery Database, and noted that a cohort of neonates who underwent BT shunt placement without
concomitant procedures experienced discharge
mortality rate of 7.2% and composite morbidity of
13.1% [11].
The ICU management for both PDA stenting and
surgical shunt has almost similar outcomes. Glatz
et al. [1] in their recent multicenter comparison between PDA stenting and BT shunt demonstrated
that both duration of mechanical ventilation and
LOS in ICU and in hospital are shorter in the stent
group compared with the surgical shunt group,
which generally correlates with our results.
One case from each group in this study showed
signs of low cardiac output and required peritoneal
dialysis because of acute kidney injury. Low cardiac
output may be related to the nature of congenital
heart disease itself and not to the stealing phenomena, although the appropriate and adequate
size of stent or even the surgical shunt for each body
weight is not well known [7].
Nevertheless, short-term outcomes should not be
the only focus. Long-term outcomes in infants with

ductal-dependent pulmonary blood ﬂow are more
challenging. Although most published papers,
which investigated pulmonary growth as the target
of palliative procedure, found that PDA stenting was
equal, if not superior, to surgical shunt in achieving
adequate growth of PA branches, Santoro et al.
[5,12,13] performed a series of studies to investigate
the growth and symmetry of PA following stent
placement or surgical shunting, and found no difference in outcome between these two procedures.
By contrast, Glatz et al. [1] reported that the stent
group achieved better growth and symmetry of
pulmonary branches compared with the group that
underwent surgical shunting. In our study, however, we found no difference in the growth of pulmonary branches between the two groups, with
both presenting adequate growth at the time of
second-stage surgery. Although the Nakata score
for both groups in this study was less than 200 mm2/
m2, we did not prevent patients from undergoing
second-stage surgery as far as the Z score of their
pulmonary branches were above e2 standard deviations, considering that the lower limit of Nakata
score is not yet well determined. Although the
Nakata score of 250 mm2/m2 is generally accepted as
the cutoff for surgery, Itatani et al. [14] investigated
the lower limit of PA index that can be accepted in
patients undergoing Fontan operations and found
that only those with pulmonary index below
110 mm2/m2 will have exercise intolerance and
increased pressure in their Fontan circulation.
Adachi et al. [15] reported that patients with pulmonary index less than 250 mm2/m2 will have
acceptable function after Fontan operation. However, according to some, the lowest Nakata score to
preclude a patient from surgery is not yet known
and they instead suggest the Lower Lobe Index (LLI)
as a more informative parameter than Nakata index
in selecting patients for surgery because it is not
affected by iatrogenic distortion of proximal pulmonary branches which may happen following
aortopulmonary shunting and can be repaired
during second-stage surgery. Furthermore, LLI is
more predictive in evaluating the adequacy of the
pulmonary vascular tree before surgery [16].
The timing of second stage surgery is important,
as the durability of stent is limited. Patients with
stents should have frequent follow-ups to assess
their oxygen saturation and undergo detailed
echocardiography or even elective reintervention
(balloon dilation or restenting) to avoid disastrous
outcome and to prolong the longevity of shunt [1].
The median age at the time of corrective surgery in
our successful stent group was around 9 months,
although these patients experienced lower oxygen
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saturation, compared with the surgical shunt group,
in which patients survived longer (up to 12 months
with better oxygen saturation; Table 1).
Sivakumar et al. [17] studied the durability of
stents in a small group of patients and concluded
that a stent may be enough for single ventricle patients; however, corrective surgery should be performed earlier in patients with biventricular repair
following stent placement (within 5e14 months vs.
8e15 months in single ventricle patients). Vida et al.
[9] studied the surgical outcome post-PDA stent
placement and found that 53% of the stented patients needed reintervention to bridge them to second-stage palliation at a mean age of 11 months
with mean oxygen saturation of 79%.
Because we did not perform elective reintervention in our center, our patients had less oxygen
saturation following corrective surgery in comparison with patients who underwent surgical shunting.
The exact half-life of stent remains unknown, but
it has been reported that endothelialization in the
mesh of stent occurs as early as 1 month following
stent insertion [18]. Senator et al. [12] reported that
45% of stented PDA will close in 4 months.
Future changes in stent design are expected to
reduce endothelial reaction. Some authors have reported novel drug-eluting stents coated with polypeptide to inhibit neointimal hyperplasia and
reduce vascular smooth muscle proliferation. However, the safety and efﬁcacy of such novel stents are
not proven yet [19]. For now, repeated dilation may
offer a temporary solution for endothelial proliferation in the stented duct.
Because both surgical aortopulmonary shunt and
PDA stent will cause some distortion to PA
branches, we compared the need for additional interventions on the pulmonary arteries during second-stage surgery between the two groups. About
80% of successful stent cases in our study needed
reconstruction of either main PA or its branches,
whereas only 60% required reconstruction in the
failed stent group. Some authors [9] reported the
need for reintervention in 46% of their cases before
reaching the ﬁnal surgery stage, with 53% of the
cases requiring PA enlargement and plasty during
second-stage surgery. By contrast, in the study by
Vida et al. [9], among 13 patients who received a
PDA stent, nearly half required additional pulmonary arterioplasty at the time of complete surgical
repair and four needed additional PA interventions
at a later period.
Although PDA stents have a tendency to develop
neointimal proliferation over time, which may affect
their patency and durability [1], and thus patients
may require reintervention in the form pulmonary
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plasty, in a good number of cases, the stenting appears to be an alternative noninvasive procedure
comparable to surgical systemic-to-pulmonary
shunting to prepare patients for second-stage
surgery.
The major limitation of this study is the lack of
proper randomization with a small number of surgical shunt patients included because of our
preferred approach to stent ductal-dependent pulmonary circulation rather than dividing patients
randomly to receive interventional or surgical options, which biases the procedure selection.

5. Conclusion
It is reasonable to assume that PDA stenting is a
growing noninvasive approach for initial palliation
of ductal-dependent pulmonary circulation with
acceptable outcome and smoother postprocedure
care. On the mid-term follow-up, the procedure was
successful in achieving its target in 70% of cases
with results comparable to surgical shunt.
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